Apigenin Inhibits the Progression of Osteoarthritis by Mediating Macrophage Polarization

Xueyan Ji1, Wei Du2, Wenqing Che1

  • 1Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.

Abstract

Insights

Apigenin protects against osteoarthritis (OA) by reducing cartilage damage and inhibiting inflammation. It modulates macrophage polarization and alleviates chondrocyte apoptosis via the TRPM7-mTOR pathway.

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • Osteoarthritis (OA) is characterized by chondrocyte injury and inflammation.
  • Macrophage polarization plays a critical role in OA pathogenesis.
  • Apigenin is a natural compound with potential therapeutic properties.

Purpose of the Study:

  • To investigate the mechanism of macrophage polarization in chondrocyte injury in OA.
  • To evaluate the protective effect of apigenin on chondrocytes in OA.

Main Methods:

  • Primary chondrocytes and macrophages were used in a Transwell co-culture system.
  • Experimental OA was induced in mice using modified Hulth surgery.
  • Apigenin's effects were assessed using qPCR, Western blot, histological staining, and immunohistochemical analysis.

Main Results:

  • Apigenin demonstrated a protective effect on cartilage degeneration in OA mice.
  • Apigenin reduced pro-inflammatory mediators (IL-1, IL-6, MMP3, MMP13) and modulated macrophage polarization (inhibited M1, promoted M2).
  • Apigenin alleviated chondrocyte inflammation and apoptosis by affecting the TRPM7-mTOR and MAPK pathways.

Conclusions:

  • Apigenin alleviates cartilage injury in OA by inhibiting chondrocyte inflammation via the MAPK pathway.
  • Apigenin mitigates macrophage-polarization-induced inflammation and chondrocyte apoptosis through the TRPM7-mTOR pathway.

Related Concept Videos